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Abstract 
Background: Decision-making is reported to be impaired in anorexia 
nervosa (AN) and bulimia nervosa (BN), but the influence of mood status, 
pathophysiological eating, and weight concerns on the performance of 
decision-making ability between AN and BN is still unclear. The aims of 
this study were to investigate differential impairments in the 
decision-making process between AN, BN, and healthy controls (HC), and 
secondly, to explore the role of mood status, such as anxiety, depression, 
pathological eating, and weight concerns, in decision-making ability.  
Methods: Patients suffering from AN (n=22),  BN (n=36) and age-matched 
HC (n=51) were assessed for their decision-making abilities using the Iowa 
Gambling Task (IGT).  Self-reported questionnaires including the Eating 
Disorder Examination Questionnaire  (EDE-Q), the Bulimia Investigatory 
Test, Edinburgh (BITE), the Eating Disorders Inventory,  the Maudsley 
Obsessive-Compulsive Inventory measuring obsessive-compulsive traits, 
the Hospital Anxiety and Depression Scale , and the Toronto Alexithymia 
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Scale were used to assess pathological eating concerns and attitude to 
feelings.  
Results: Significant differences in IGT performance were observed between 
BN and HC. Significant negative correlation was found between IGT 
performance and the BITE symptom subscale in AN. In BN, there was a 
negative correlation between the EDE-Q weight concerns subscale and IGT 
performance. It was also found that increased anxiety, depression, and 
eating/weight concerns predicted poorer decis ion-making. 
Conclusion: Different patterns of association between pathological eating 
concerns/behaviors and performances in decision-making ability were found 
between AN, BN, and HC. Anxiety, depressive mood status, and 
eating/weight concerns were related to decision-making ability.  
Keywords: Anorexia nervosa, Bulimia nervosa, Decision-making, Iowa 
Gambling Task, Weight-concern, Anxiety, Depressive mood 
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Introduction 
Eating disorders (EDs) are severe and enduring psychiatric disorders of 
eating behavior, including extreme, unhealthy decreases in food intake as 
well as severe overeating, accompanied by feelings of distress or excessive 
concern about body shape or weight  [1]. Three types of eating disorders are 
recognized by the text revision of the fourth edition of the Diagnostic and 
Statistical Manual of Mental Disorders (DSM-IV-TR)[2]: anorexia nervosa 
(AN), bulimia nervosa (BN), and eating disorder not otherwise specified 
(EDNOS). 
Decision-making is affected by the combination of emotional 
representations, sensitivity to immediate reward and long-term outcome 
according to the somatic marker hypothesis (SMH)[3–5]. Multiple cognitive 
functions such as attention, memory, learning [6, 7], risk-taking, and 
obsessive-compulsive traits  [8] have been suggested as being involved in 
performances in decision-making [9, 10]. A previous study by Tchanturia et 
al. found impairment of emotional signal by skin conductance (SCR), 
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showing the lowest emotional signal by demonstrating a lack of ability to be 
aware of emotional signal during decision-making task [11]. In BN, a 
previous study showed no significant correlation between SCR and 
performance in decision-making [12]. For this reason, it is unclear whether 
the AN and BN groups have different deficits in emotional skills during 
decision-making. 
The role of emotion, specifically anxiety or worry, may influence the 
decision-making process [13]. High levels of worry may have expected 
consequences of future events that influence the performances of 
decision-making [14]. The majority of people with EDs have high levels of 
anxiety [15], worry, a defining cognitive feature, and a maintenance factor 
of anticipatory anxiety [16]. Heightened anxiety levels may affect  the 
process of decision-making in AN or BN patients. However,  few studies 
have focused on the effect of mood status on a prospect during the 
decision-making process in AN compared with BN. Two studies showed that 
decision-making in patients with AN may be related to anxiety [17, 18], 
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whereas other studies showed that they were unrelated [7, 19]. Some studies 
suggested significant associations between measures of depressiv e disorder 
and decision-making [20, 21], but a number of other studies have indicated 
that depressive symptoms did not significantly influence decision -making 
ability in patients with EDs [7, 12, 22–24]. 
Alexithymia is commonly described as consisting of four features: (1) 
difficulty identifying and describing subjective feelings; (2) difficulty 
distinguishing between feelings and the bodily sensations of emotional 
arousal; (3) lack of fantasy; and (4) an externally orientated cognitive style 
[25]. Previous studies demonstrated that patients with EDs use maladaptive 
eating behaviors (e.g., binging, purging, or dietary restriction) as a way to 
avoid or cope with their emotions [26, 27], with many clinical studies 
suggesting that eating disorder symptoms are associated with emotional 
dysfunction [28, 29], with clear functional links expressed between 
emotional states and both bulimic and restrictive pathology. It has been 
suggested that patients with EDs tend to show alexithymia, but only one 
9 
 
study has examined the relation in EDs in comparison with healthy controls 
(HC), showing that alexithymia was  unrelated to decision-making in AN 
[30].  
The Iowa Gambling Task (IGT) is a neuropsychological task that  tests 
the decision-making ability to sacrifice immediate rewards in order to 
achieve long-term gain [3]. IGT assesses set-shifting ability, reaction to 
reward and punishment, and learning ability to decide advantageous over 
disadvantageous choice under uncertainty [31]. IGT is underpinned by SMH, 
a theory that, in essence, posits that decision -making under uncertainties is 
guided by emotional responses to anticipated positive and negative 
consequences [5,6]. Neuroimaging findings suggest that activation of the 
mesolimbic pathway during wins and decreased activation of the inferior 
frontal gyrus during losses lead to repeated selections in reward and 
punishment in IGT [32]. IGT was developed for functional assessment, 
given that patients with ventromedial prefrontal cortex ( vmPFC) and limbic 
system dysfunction show severe impairments in decision -making.  
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 Increasing evidence suggests neuropsychological traits such as poor 
set-shifting ability [19], weak central coherence [19, 33], a dysfunction of 
the reward circuit, including a preference for immediate reward despite 
long-term adverse consequences [15], higher sensitivity to punishment [34], 
and poor insight into illness [35, 36] in AN. In previous studies, memory 
function [37], skin conductance response [11], body mass index (BMI) [38], 
anxious mood [18] and impaired decision-making ability were indicated in 
AN. Regarding the domain of decision-making ability, several studies have 
reported that individuals with AN show impaired decision-making ability as 
reflected by poorer performance on IGT [11, 22, 39–41].  
In BN, decision-making ability was impaired in some studies [12, 22, 
41], showing that obsessive-compulsive traits [42] and pathological eating 
symptoms may be related to impaired decision-making ability, which in turn 
may lead to real-life risk-taking and immediate reward-seeking behavior 
such as binge eating and purging.  
Thus, in total, relatively few studies have been conducted concerning 
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the decision-making ability between AN, BN and HC [12, 37, 43, 44]. In 
addition, it has remained unclear whether the performances of 
decision-making are distinguished by pathological eating 
concerns/behaviors, mood status (anxiety, depression), and attitude to 
feelings such as alexithymia between AN, BN, and HC.   
The hypotheses of this study were: 1) decision-making performances 
can be distinguished in AN, BN and HC, and 2) decision-making deficits are 
related to mood status such as anxiety, depression, alexithymia, and 
pathological eating symptoms.  
The aims of this study were to investigate differential impairments in  
the decision-making process between AN, BN, and HC, and secondly, to 
explore the role of mood status such as anxiety, depression, attitudes to 
feelings, and pathological weight concerns in decision-making ability.  
 
Materials and Methods 
Participants 
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The patients of this study were 58 females recruited from Chiba 
University Hospital , Japan (22 AN; 36 BN). They were interviewed by a 
senior psychiatrist assessing criteria for AN and BN as defined by DSM-IV 
[2]. In addition, the M.I.N.I. International Neuropsychiatric Interview 
translated into Japanese (M.I.N.I.)[45] was applied. Exclusion criteria for 
patients with AN and BN were a history of brain injury, epilepsy, psychosis 
or drug dependence. The AN group included restrictive (n = 9) and binge  
eating/purging (n = 13) subtypes. The BN group included purging (n = 34) 
and non-purging (n = 2) subtypes. A total of 7 females (2 AN and 5 BN) had 
the following comorbidities: dysthymia (5%; 3 with BN), panic disorder 
(2%; 1 with BN), somatoform disorder (2%; 1 with AN), anxiety disorder 
(2%; 1 with AN), and alcohol dependence (2%; 1 with BN). Seventeen 
percent of all patients were taking serotonergic drugs (SSRIs)  (Table 1). 
HC (n = 51) were recruited through local advertisements and a website 
from a potential pool of university students and volunteers. Age-matched 
HC underwent an interview by a senior psychiatrist using M.I.N.I. [45], and 
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they were determined to have no family history of psychiatric conditions, 
history of brain injury, epilepsy,  psychosis, current substance abuse or 
dependence, risk of suicide, mental retardation, autistic spectrum disorders, 
comorbid depression and bipolar disorders, and that their BMI (body mass 
index) was between 19 and 25 kg/m
2
.  
Procedures 
All participants, female native Japanese speakers , were between age 18 
and 38 (mean = 24.92, SD = 5.83 years). After the study had been described 
to the participants,  their written informed consent was obtained. The ethics 
committee of the Chiba University Graduate School of Medicine approved 
the study protocol.   
 
Measurements 
Instruments 
・Toronto Alexithymia Scale  (TAS-20)  
The Toronto Alexithymia Scale  [46, 47], Japanese version with 
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established validity and reliability [48], is a 20-item self report 
questionnaire measuring alexithymia.  It includes three subscales: difficulty 
identifying feelings, difficulty describ ing feelings, and externally oriented 
(concrete) thinking. Cut-off scores for TAS-20 are equal to or less than 51 
for non-alexithymic individuals, and equal to or greater than 61 for 
alexithymia. Scores of 52-60 indicate possible alexithymia.  
 
・Hospital Anxiety and Depression Scale (HADS)  
The Hospital Anxiety and Depression Scale  [49], Japanese version 
established as valid and reliable [50], is a widely used self-report scale 
developed to detect states of depression, anxiety and emotional distress 
among patients being treated for a variety of clinical problems.  The scale 
consists of eight questions assessing depression (HADS -d) and eight 
assessing anxiety (HADS-a). The optimal cut-off point is said to be greater 
than or equal to 8 for the identification of suspicious cases and greater than 
or equal to 11 for safe cases on both subscales [49].  
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・Eating Disorder Examination Questionnaire (EDE-Q)  
 The Eating Disorders Examination Questionnaire [35], Japanese 
version, which was established for its validity as well as reliability  [52], is a 
widely used 36-item self-report questionnaire that assesses the eating 
disorders-related level of symptoms over the past 28 days.  EDE-Q generates 
two types of data. First, 22 scaled items plus one unscaled item ( items 1-15 
and 29-36) provide subscale scores reflecting the severity of aspects of the 
ED psychopathology.  Second, 13 more items (items 16-28) provide data on 
six key behavioral features of ED in terms of presence/absence and 
frequency with which the behavior occurred, and loss of control. EDE-Q 
includes four subscale scores, Restricting (EDE-Qr), Eating concern 
(EDE-Qe), Shape concern (EDE-Qs) and Weight Concern (EDE-Qw), which 
are included in this assessment, the response format of which is a 7-point 
Likert-type scale (0: never; 6: every day). The subscale scores are obtained 
by calculating the average of the items forming each subscale, and the 
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global score (EDE-Qg) is the average of the four subscale scores.  
 
・Bulimia Investigatory Test, Edinburgh  (BITE)  
The Bulimia Investigatory Test, Edinburgh [53], Japanese version, 
recognized for its validity and reliability [54], is a 33-item self-report 
measure designed to identify individuals with symptoms of bulimia or binge 
eating. BITE consists of two subscales: the symptom scale (BITE-sas), 
which measures the degree of symptoms present, and the severity scale 
(BITE-ss), which provides an index of the severity of binging and purging 
behavior as defined by their frequency.  
 
・Eating Disorders Inventory-2 (EDI-2)  
The Eating Disorder Inventory-2 contains 91 items and is a self-report 
questionnaire designed for use with those aged 12 years or older. This 
measure assesses features commonly associated with anorexia nervosa and 
bulimia nervosa but does not provide diagnoses for eating disorders [55]. 
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EDI-2 consists of 11 subscales including bulimia, body dissatisfaction, 
drive for thinness, perfectionism, ineffectiveness, interpersonal distrust, 
interoceptive awareness, maturity fears, asceticism, impulse regulation and 
social insecurity. The Japanese version of EDI-2, which has been 
established as valid and reliable [56], was used to assess the presence of 
eating disorders. 
 
・Maudsley Obsessive-Compulsive Inventory (MOCI)  
The Maudsley Obsessive-Compulsive Inventory [57], Japanese version, 
recognized as being valid and reliable [58], is a true-false format self-report 
questionnaire developed for evaluating obsessive -compulsive symptoms to 
discriminate obsessive patients from other neurotic patients and nonclinical 
individuals. The test is composed of 30 dichotomous items,  such that the 
total score for a participant will range between 0 (absence of symptoms) and 
30 (maximum presence of symptoms) . 
The levels of psychopathology in eating disorders were measured using 
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the scores of BITE, total scores of EDI-2, and EDE-Q subscores. 
 
Neuropsychological Assessment  
・ Iowa Gambling Task  [3, 59] 
Decision-making ability of participants  was evaluated using IGT, 
which is a neuropsychological task based on emotion-guided evaluation.  
Participants are required to choose one card at a time from four available 
decks of cards (100 trials) in this task. The goal of the task is to win as 
much money as possible. To accomplish a task, participants have to detect, 
from a long-term perspective, which are the most advantageous decks . First, 
participants were given both the task instructions and 200,000 Japanese yen 
(approximately US$1,666) of play money. Each time participants choose a 
card, they will win some money; however, on turning over each card they 
also will, seldom or sometimes, have to pay a penalty according to a 
pre-programmed schedule of reward and punishment.  Gains and losses 
differ for each card selected from the four decks. Decks A and B are “bad 
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decks (disadvantageous)”, and the other decks, C and D, are “good decks 
(advantageous)”,  because, in the former, while participants receive 10,000 
Japanese yen (approximately US$83), the losses are also higher, such that 
these decks cost more in the long run. In contrast, the latter will lead to 
overall gains in the long run (receiving less money, but punishments are 
also smaller). The 100 choices were divided into five blocks of 20 choices 
each. We calculated the number of advantageous cards  (decks C and D) 
selected in total. 
 
Statistical Analyses 
All statistical analyses were performed using SPSS 21.0  (IBM Corp., 
Armonk, NY). Demographic and clinical variables for ED and HC groups 
were compared using one-way analyses of variance (ANOVAs).  
IGT scores were defined as the number of choices from the 
advantageous decks (C and D) minus the number of choices from the 
disadvantageous decks (A and B) for all 100 trials. This net score 
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(decks[C+D] - decks[A+B]) calculated for each 20-choice time block 
enables the assessment of learning during the task. A total net score for the 
100 selections is also calculated. A score of <10 was established by Bechara 
et al. as the threshold for deficit of decision-making on IGT, given the 
maximum net score achieved by vmPFC patients was <10  [9]. A 5 × 3 
repeated-measures ANOVA was carried out with the net scores of the five 
blocks [C+D]-[A+B](1-20, 21-40, 41-60, 61-80, 81-100) as the 
repeated-measures variable and the three diagnostic groups (AN, BN, and 
HC) as a between-subjects variable. Effect size was calculated using 
Cohen’s d, with d=0.2 regarded as a small effect, d=0.5 as a medium effect , 
and d=0.8 as a large effect  [60]. Pearson’s correlations were used to 
examine the relationship between IGT performance and demographic and 
clinical variables in the whole sample and in each group, respectively. 
Finally, multiple regression analysis was performed for all participants to 
detect the best predictors of IGT performance, using IGT performance as 
the dependent variable and all questionnaire scores and subscale scores 
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showing significant relationships as independent variables.  In all analyses, 
the statistical significance level was set at p < 0.05 (2-tailed tests).  
 
Results 
Sample characteristics 
Demographic and clinical characteristics are summarized in Table 1. 
The three groups did not differ in terms of  age (F (2,106) = 1.71; p =0.19) 
and education (F (2, 65) = 1.24; p = 0.30). In addition, no significant 
difference between the patient groups in terms of illness duration was found 
(F (1, 52) = 0.003; p < 0.096). On the other hand, significant differences 
were obtained for BMI and clinical self-report measures (TAS-20, EDE-Q, 
HADS, BITE, MOCI, and EDI-2). Post hoc t  tests revealed that AN and/or 
BN differed from HC for most of the dimensional assessments, while no 
significant differences were found with respect to the overall questionnaires 
between AN and BN.   
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Decision-making Performances 
Group comparisons in IGT total net scores [C+D]-[A+B](1-100 choices) 
Results from IGT are presented in Table 2. The prevalence of 
decision-making impairment (IGT < 10, [9]) was approximately 45% in AN,  
44% in BN patients, and 45% in HC. No significant group differences were 
found in the mean IGT total net scores (F (2,103) = 1.06; p = 0.35), 
indicating that the decision-making abilities of the three groups were quite 
similar.  
 
Group comparisons in IGT block net scores [C+D]-[A+B](1-20, 21-40, 
41-60, 61-80, 81-100) 
Figure 1 shows the mean IGT scores for the three groups over the five 
blocks of 20 trials each. A 5 (IGT block) × 3 (group) repeated measures 
ANOVA was performed on net scores for all five blocks. Mauchly’s  test 
indicated that the assumption of sphericity had been violated (χ 2 (9) = 51.51, 
p < 0.0001), and therefore the degrees of freedom were corrected using 
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Greenhouse-Geisser estimates of sphericity (ε = 0.78). There was no 
significant main effect of group (F (2, 103) = 1.06, p = 0.35, ηp2 = 0.02), 
but there was a significant main effect of block (F (3.14, 57.48) = 14.53, p < 
0.0001, ηp2 = 0.12), and a significant group × block interaction (F (6.28, 
57.48) = 2.63, p = 0.02, ηp2 = 0.05) over the IGT blocks. In the HC group, 
IGT performance showed a gradual increase across blocks. There was a 
significant task-related learning effect, as performance improved during the 
task for BN and HC (BN: F (4, 32) = 2.69; p = 0.04; HC: F (4, 47) = 15.24; 
p < 0.0001). A post-hoc least significant difference test indicated that there 
was a significant difference between the BN and HC groups  in the final 
block [C+D]-[A+B](81-100), that is, performance in BN was significantly 
worse than in HC (p = 0.02). On the other hand, although no significant 
difference was observed between AN and HC in the final block 
[C+D]-[A+B](81-100), performance in AN was marginally deficient 
compared to HC (p = 0.054). The two clinical groups were not significantly 
different from each other in any other block. Effect  sizes for 
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between-groups differences in IGT net scores were measured using Cohen’s 
d (block 1: AN vs. HC, d = 0.20; BN vs. HC, d = 0.11; block 2: AN vs. HC, 
d = 0.36; BN vs. HC, d = 0.36; block 3: AN vs. HC, d = 0.13; BN vs. HC, d 
= 0.30; block 4: AN vs. HC, d = 0.35; BN vs. HC, d = 0.42; block 5: AN vs. 
HC, d = 0.50; BN vs. HC, d = 0.56). 
 
Group comparisons controlling for covariates 
We demonstrated the same group comparisons analysis, controlling for 
the use of SSRIs in the IGT block net scores [C+D]-[A+B](1-20, 21-40, 
41-60, 61-80, 81-100). We not only detected remaining significant 
differences in the IGT net scores in the final [C+D]-[A+B](81-100) choices 
(p = 0.01), but also found significant differences between BN and HC in the 
fourth [C+D]-[A+B](61-80) choices (p = 0.01).  
 
Association between Decision-making and Clinical Variables 
Correlation analysis 
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We explored correlations among clinical measures including all scores 
such as TAS-20, EDE-Q, BITE, EDI-2, HADS, MOCI and IGT performance 
(both IGT total net scores: [C+D]-[A+B](1-100 choices) and block net 
scores: [C+D]-[A+B](1-20, 21-40, 41-60, 61-80, 81-100) ) in AN and BN 
females, respectively.  Performance in the first block [C+D]-[A+B](1-20) of 
the IGT was negatively associated with  BITE-sas in the AN group (r = -0.73, 
p = 0.04) (Figure 2). In the BN group, as shown in Figure 3, the IGT 
performance in the third block [C+D]-[A+B](41-60) was also negatively 
correlated with EDEQ-w (r = -0.47, p = 0.02). Therefore, we detected 
different patterns of association between pathological eating concerns/ 
behaviors and the performances of decision-making ability between AN and 
BN.  
 
Regression analysis 
Multiple regression analysis was performed for all participants using 
demographic and clinical scores such as TAS-20, EDE-Q (four subscales: 
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restricting, eating concern, shape concern, weight concern), HADS 
(depression and anxiety), EDI-2, MOCI, and BITE (symptoms and severity) 
as independent variables and IGT net scores [C+D]-[A+B] (1-20, 21-40, 
41-60, 61-80, 81-100) as dependent variables. As shown in Table 3, the 
analyses revealed seven predictive factors for the third block of IGT 
[C+D]-[A+B](41-60): years of education (β = 0.77, p = 0.0001), EDEQ-r (β 
= 1.58, p = 0.0001), HADS-a (β = -0.69, p = 0.01), HADS-d (β = 1.44, p = 
0.0001), EDI-2 (β = -0.81, p = 0.01), BITE-ss (β = -0.51, p = 0.03), and 
BITE-sas (β = -1.80, p = 0.0001). In contrast, no significant predictive 
factor was highlighted for the AN and BN groups, suggesting that mood 
status (anxiety or depression), in addition to the pathological eating/ weight 
concerns for the prospect of decision-making were detected. 
 
Discussion 
In the present study, we found different profiles in IGT performance 
between BN, AN, and HC. As shown in Figure 1, a comparison of the 
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performance curves of the three groups revealed that the individuals with 
AN and BN, as opposed to HC, failed to learn advantageous 
decision-making until the end of the task . Although no significant 
difference between AN and HC was observed, a difference between BN and 
HC (BN < HC, p = 0.02) was detected in the final block 
[C+D]-[A+B](81-100). Regarding total net scores, the prevalence of 
decision-making impairment (IGT < 10) was reported to be approximately 
61% in AN and 77% in BN by Brogan et al. [44] , but our data showed lower 
percentages. Secondly, only in the BN group, there was a significant 
negative correlation between the weight concern subscales and the 
performances of decision-making ability. These findings may be strongly 
confirmed by the fact that in the BN group, pathological weight concern 
affected the impaired decision-making ability.  
A previous study has reported that patients with BN were significantly 
different from the HC group in blocks 3  [C+D]-[A+B](41-60) and 4 
[C+D]-[A+B](61-80) [44]. In contrast, we found that BN made fewer 
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advantageous choices than HC in the final block [C+D]-[A+B](81-100) of 
the task. This would suggest that pathological concerns affect ignored 
long-term negative consequences, which may have led to impaired 
decision-making ability in the final block [C+D]-[A+B](81-100) in the 
current study. There is a striking resemblance between the IGT performance 
of the patients and their real -life pathological behaviors , in which they have 
a tendency to reduce their food intake and/or refuse to eat, or in contrast  to 
this pattern, repetitively overeating and purging, ignoring long -term 
negative consequences.  In a previous study, BN subjects failed to learn an 
advantageous decision-making strategy by choosing immediate rewards 
(high gains) despite the long-term negative consequences (loss of money) as 
compared to HC, showing that sensitivity to gains affect these findings [23], 
results consistent with the current study. Boeka and Lokken [22] suggested 
that there are links between decision-making, weight, and eating 
concerns/restricting behavior in BN, and thus the authors argued that the 
severity of bulimic symptoms as measured by the Bulimia Test -Revised [61] 
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and the severity of EDE-Q (restraint, eating concerns and weight concerns) 
contribute to decision-making ability. These data were consistent with the 
findings in the BN group in the current study. Brand et al. suggested that 
performance in decision-making was related to executive functioning but 
not to other neuropsychological functions, personality, or disease -specific 
variables in the BN group [41]. Regarding the task, in comparison to HC, 
the patients with BN tended to choose disadvantageous alternatives more 
frequently, possibly due to a tendency to fail to learn from the anterior half 
of the task, which might be linked to real-life pathological behaviors.  
On the other hand, although performance in AN was marginally 
deficient compared to HC (p = 0.05) in the last trial [C+D]-[A+B](81-100) 
of the IGT, the current study does not support results from other studies [11, 
39, 40], showing that  AN patients failed to reach a significant difference in 
decision-making compared to HC. One explanation for this is the small 
sample size of the current study. Additionally, the fewer comorbidities (AN, 
2 with comorbidities; BN, 5 comorbidities) in AN might have led to better 
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decision-making compared to BN. Interestingly, in the AN group, there was 
a significant correlation between bulimic symptomatology measured by the 
BITE symptom subscale, which measures the degree of present symptoms, 
and the poor performance of IGT in the first block  [C+D]-[A+B](1-20). 
59.1% (13/22) of the AN group had binge eating/purging subtype, which 
may have affected the poor performance of IGT. Thus, our first hypothesis , 
that the AN and BN groups present a different pattern in decision-making 
ability, was confirmed.  
The second aim of this study was to  explore the links between 
decision-making ability and mood status, weight/eating concerns of 
pathological symptoms. Using multiple regression analysis , we found that 
EDI-2 and BITE-ss measures predicted decision-making. These data are in 
line with previous investigations concerning this subject [18, 22].  
Both the states of anxiety and depressive mood were found to be 
predictors of better decision-making. These data suggest that emotional 
states may impact decision-making in EDs [11] as well as in HC [62–64]. 
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Zeeck et al. reported that the urge to eat is significantly higher under 
negative-emotional states; negative emotions such as sadness or 
disappointment correlated significantly with the number of binges, whereas 
positive emotions did not [65]. Thereby, the ‘Network Theory of Affect’ [66], 
that is, affective nodes (central units) , can be semantic (with 
straightforward meaning) or affective (with emotional meaning) , which may 
confirm the findings of the previous study. One recent study of binge eating 
disorders was in line with this view, proposing that the emotional state may 
have a direct experience that is similar to its emotion [67]. 
Alexithymia, as measured by TAS-20, did not affect decision-making 
ability in the current study, although a higher level of alexithymia compared 
with HC was observed. Miyake et al. reported that there was no correlation 
with decision-making ability using emotional decision-making task and 
alexithymia in EDs [30], a result consistent with the finding of our study.  
In the current study, control ling for the use of SSRIs as covariance, we 
detected significant difference in IGT performances between BN and HC in 
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the fourth block [C+D]-[A+B](61-80) and the final block 
[C+D]-[A+B](81-100), which suggested the influence of the serotonin 
system in decision-making. In the previous study by Tchanturia et al . [11], 
44% of AN patients were taking SSRIs, but no difference between 
medicated and non-medicated patients was found. Emerging data have 
suggested that dysregulation of serotonin circuits in cortical and limbic 
structures are related to anxiety, eating behaviors and body image symptoms 
[68]. Alterations of this system may influence mood status and 
decision-making process in EDs, which may lead to insights into potential 
treatment approaches.  The question of whether cognitive impairment in EDs 
is an endophenotype and risk factor or whether it  is a correlate of illness 
remains unclear from the findings in the current study. It may be suggested 
that the relationship of symptomatology and emotional functioning to 
decision-making performance improves with recovery of illness. 
There are some limitations to this study. First, it should be noted that a 
single task such as IGT is limited in examining decision-making 
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impairments comprehensively, and this is true for the other clinical scales 
as well. Second, the results are generalizable for females only, and the 
sample sizes were not large enough compared to previous studies [12, 37, 
43, 44], indicating that a replication with a larger group that includes males 
is desirable. Finally, other variables  such as impulsivity, central coherence, 
set-shifting, and inhibitory control-confounding factors associated with 
decision-making deficits or emotional dysregulation  should be considered 
in the future. 
Future study should evaluate how some different emotional variables 
such as sadness and fear may influence the decision-making process in 
patients with EDs. A longitudinal study is required to investigate changes in 
decision-making ability in accordance with emotional states and recovery of 
symptomatology of illness.  
In conclusion, we found different profiles in IGT performance between 
BN, AN, and HC. Different patterns of association between pathological 
eating concerns/behaviors and the performances of decision-making ability 
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were found between AN, BN, and HC. Individuals with BN, compared to HC, 
have a different processing pattern of decision-making ability that may be 
linked to pathological eating/weight concerns. Anxiety, depressive mood 
status, and pathological eating/weight concerns are linked to 
decision-making ability.  
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Observed mean, M (SD) F p
Mean SD Mean SD Mean SD
Age (years) 25.77 6.26 25.94 5.81 23.82 5.58 1.71 0.19
Education (years) 13.23 2.20 14.07 1.87 14.00 0.91 1.24 0.30
Duration of illness (only AN, BN) 7.24 6.47 7.15 5.80 ー ー 0.00 0.96
BMI (kg/m
2
) 15.87 2.62 19.76 2.38 20.99 1.71 76.83 0.00
TAS-20 60.07 7.95 64.00 8.16 49.50 9.71 26.89 0.00
HADSa 11.06 4.29 12.00 3.87 4.61 3.39 42.55 0.00
HADSd 9.18 4.79 11.32 4.43 3.37 3.14 41.38 0.00
EDE-Qg 3.23 1.60 3.97 1.26 1.07 0.89 59.89 0.00
EDE-Qr 3.00 1.89 3.17 1.62 0.68 0.81 39.78 0.00
EDE-Qe 3.39 1.70 3.72 1.63 0.47 0.64 75.27 0.00
EDE-Qw 3.74 1.32 4.32 1.45 1.44 1.29 44.73 0.00
EDE-Qs 3.96 1.23 4.56 1.23 1.70 1.25 50.96 0.00
BITEss 8.75 6.32 11.57 5.56 1.37 1.18 67.76 0.00
BITEsas 17.63 10.14 22.61 4.38 5.33 4.46 104.27 0.00
EDI-2 117.06 43.93 139.83 37.19 60.64 29.77 52.29 0.00
MOCI 10.47 5.93 13.55 6.21 7.17 3.34 15.83 0.00
Comobidities; n=
  Dysthymia - 3
  Panic disorder - 1
  Somatoform disorder 1 -
  Anxiety disorder 1 -
  Alcohol dependence - 1
Medication; n=
  SSRIs - 10
BMI: body mass index; TAS-20: Toronto Alexithymia Scale; EDE-Qg: Eating Disorder Examination Questionnaire (global score); EDE-Qr: restricting; EDE-Qe: eating concern; EDE-
Qw: weight concern; EDE-Qs: shape concern; HADSa: Hospital Anxiety and Depression Scale (anxiety); HADSd: Hospital Anxiety and Depression Scale (depression); BITEsas: Bulimia
Investigatory Test, Edinburgh: (symptom scale);  BITEss:  Bulimia Investigatory Test, Edinburgh (severity scale); MOCI: Maudsley Obsessive-Compulsive Inventory; EDI-2: Eating
Disorders Inventory 2; SSRIs: selective serotonin reuptake inhibitors
In bold: p -value <0.05, n.s.: not significant
AN>HC,  BN>HC
Table  1    Demographic and clinical characteristics of anorexia nervosa patients (AN), bulimia nervosa patients (BN), and healthy controls (HC).
Eating disorders Healthy control    F-value                p-value                           Post hoc
AN (n=22) BN (n=36) HC (n=51) Post hoc
n.s.
n.s.
n.s.
BN>HC
AN>HC,  BN>HC
AN>HC,  BN>HC
HC>AN,  HC>BN,  BN>AN
AN>HC,  BN>HC
AN>HC,  BN>HC
AN>HC,  BN>HC
AN>HC,  BN>HC
AN>HC,  BN>HC
AN>HC,  BN>HC
AN>HC,  BN>HC
AN>HC,  BN>HC
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F p
IGT Mean SD Mean SD Mean SD
 Block 1 -1.43 7.46 -2.00 6.01 -2.61 5.29 0.31 0.73
 Block 2 2.19 7.45 2.18 7.21 -0.31 6.96 1.62 0.20
 Block 3 3.14 7.47 1.82 7.68 4.14 7.85 0.92 0.40
 Block 4 3.90 7.50 3.15 8.82 6.49 7.44 2.03 0.14
 Block 5 2.67 10.11 2.29 8.73 7.35 9.29 3.73 0.03
 Total net scores 10.48 25.53 7.50 27.09 15.06 20.99 1.05 0.35
In bold: p-value < 0.05, n.s.: not significant 
Table 2    Decision-making ability on the Iowa Gambling Task (IGT) in AN, BN, and HC
Eating disorders Healthy control     F-value     p-value  post hoc
AN (n=22) BN (n=36) HC (n=51) Post hoc
n.s.
BN<HC
n.s.
n.s.
n.s.
n.s.
 
 
 
Beta t p
0.77 4.40 0.00
EDE-Qr 1.58 4.45 0.00
-0.69 -2.69 0.01
HADS (depression) 1.44 4.65 0.00
BITEss -0.51 -2.33 0.03
BITEsas -1.8 -5.01 0.00
EDI-2 -0.81 -2.62 0.01
n = 109; R
2
 = 0.556; adjusted R
2
 = 0.388; SE of estimate = 6.036
SE: standard error; EDE-Qr: Eating Disorders Examination Questionnaire
restricting subscale; HADS: Hospital Anxiety and Depression Scale; BITE:
Bulimia Investigatory Test, Edinburgh; EDI-2: Eating Disorder Inventory-2
education (years)
HADS (anxiety)
Table 3    Multiple regression analysis with Iowa Gambling Task net
scores (third block: 41-60 within 100trials) as the dependent variable in
all participants. Results showed seven variables predicting performance
on the IGT.
Variables
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Figure 1   Strategy of Iowa Gambling Task, as total number of "Advantageous" minus 
"Disadvantageous" cards selected in each block of 20 cards; anorexia nervosa (AN), bulimia 
nervosa (BN), and healthy control (HC). A significant difference between BN and HC was 
indicated (p<0.05).  
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Figure 2   Scatter plot shows the scores of the first block of IGT (1-20 within 100 trials) and 
the Bulimia Investigatory Test, Edinburgh symptom subscale (BITE-sas) for AN and HC. 
Negative correlation was found in AN (r = -0.73; p = 0.04) 
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Figure 3   Scatter plot shows the scores of the third block on IGT (41-60 within 100 trials) 
and the eating disorder examination questionnaire weight concern  subscale (EDE-Qw) for 
anorexia nervosa (AN), bulimia nervosa (BN), and healthy cont rol (HC). Negative correlation 
was found in BN (r = -0.47; p = 0.02).   
 
